An NCI-designated Comprehensive Cancer Center
Lauren Gima 300px

Lauren Gima, L.C.G.C., M.S.

Cancer Risk Counselor, Division of Clinical Cancer Genomics, Department of Population Sciences
Clinical Expertise
  • Clinical Cancer Genomics
  • Hereditary Cancers
Research Focus
  • Cancer Genetics


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

Affiliate Locations

Toiyabe Indian Health Project
250 N See Vee Ln,
Bishop, CA 93514
Karuppuchamy T, Behrens E, González-Cabrera P, Sarkisyan G, Gima L, Boyer JD, Peach R. (2016). Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease. Mucosal immunology.
Karuppuchamy T, Behrens EH, González-Cabrera P, Sarkisyan G, Gima L, Boyer J, Peach R. (2016). 971a Inflammation Modulates the Sphingosine-1-Phosphate Pathway in Inflammatory Bowel Disease (IBD). Gastroenterology, 150(4), S195.
Dann SM, Manthey CF, Le C, Miyamoto Y, Gima L, Abrahim A, Cong Y. (2015). IL-17A promotes protective IgA responses and expression of other potential effectors against the lumendwelling enteric parasite Giardia. Experimental parasitology, 156, 68-78.
Veny M, Behrens E-H, Gima L, Rivera-Nieves J. Altered expression, desensitizaion and recycling of CCR9 in the TNFΔARE mouse model of Crohn’s disease. Poster Presentation. La Jolla Immunology Conference, San Diego, CA. October 2012.
Behrens E-H, Scott F, Clemons B, Veny M, Gima L, Gonzalez-Cabrera P, Peach R, Rivera-Nieves J. Sphingosine-1-phosphate pathway modulation; a novel therapeutic target for inflammatory bowel disease (IBD). Poster Presentation. La Jolla Immunology Conference, San Diego, CA. October 2012.
In The News